NEOGENOMICS INC's ticker is and the CUSIP is 64049MAB6. A total of 29 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,537,670 | -9.8% | 25,679,000 | -7.4% | 0.43% | +8.3% |
| Q2 2023 | $20,545,968 | -6.2% | 27,718,000 | -6.4% | 0.40% | -3.9% |
| Q1 2023 | $21,909,920 | +22.9% | 29,608,000 | +9.0% | 0.41% | +34.0% |
| Q4 2022 | $17,830,358 | -18.0% | 27,168,000 | -18.7% | 0.31% | -21.6% |
| Q3 2022 | $21,735,000 | +7.8% | 33,421,000 | +3.6% | 0.39% | +10.4% |
| Q2 2022 | $20,163,000 | +5.2% | 32,245,000 | +12.9% | 0.36% | +16.3% |
| Q1 2022 | $19,162,000 | +4.0% | 28,555,000 | +32.8% | 0.31% | -1.0% |
| Q4 2021 | $18,430,000 | +19.7% | 21,497,000 | +41.4% | 0.31% | +8.8% |
| Q3 2021 | $15,402,000 | +1.1% | 15,205,000 | -2.2% | 0.28% | -3.7% |
| Q2 2021 | $15,238,000 | -29.3% | 15,544,000 | -26.5% | 0.30% | -36.3% |
| Q1 2021 | $21,564,000 | – | 21,139,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 11,100 | $11,223,000 | 1.10% |
| ZAZOVE ASSOCIATES LLC | 6,125,000 | $6,225,000 | 0.73% |
| SSI INVESTMENT MANAGEMENT LLC | 7,234,000 | $7,272,000 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 21,139,000 | $21,564,000 | 0.46% |
| LINDEN ADVISORS LP | 52,450,000 | $53,265,000 | 0.39% |
| Calamos Advisors LLC | 46,516,000 | $47,037,000 | 0.26% |
| Nicholas Investment Partners, LP | 1,420,000 | $1,429,000 | 0.10% |
| Jefferies Group LLC | 10,074,000 | $10,239,759 | 0.09% |
| CQS (US), LLC | 2,600,000 | $2,702,000 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,500,000 | $2,524,000 | 0.05% |